Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Systemic endogenous receptors and circulating physiological pathways is a broad conceptual grouping rather than a specific, well-defined molecular target. In the field of pharmacology, a therapeutic target is defined as a discrete biological entity, such as a protein, enzyme, or ion channel, that can be addressed by a drug to produce a clinical effect (IUPHAR/BPS Guide to PHARMACOLOGY). This term instead refers to the collective network of endogenous signaling molecules and their corresponding receptors that maintain homeostasis and regulate systemic functions across various organs and tissues. Because it encompasses a vast array of distinct physiological systems—including the endocrine, nervous, and immune systems—it lacks the molecular specificity required for targeted drug design. Consequently, it is classified as an incorrect or overly broad designation for a drug target, as effective therapeutic interventions must focus on specific components within these pathways to ensure selectivity and minimize adverse systemic effects.
Not applicable as this is a broad physiological category rather than a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Systemic endogenous receptors and circulating physiological pathways.